Discordance in estrogen (ER), progesterone (PR), and HER2/neu status between primary
breast tumours and metastatic disease is well recognized. In this review, we highlight how …

Preclinical and clinical evidence suggests that mesenchymal stem cells (MSCs) may be
beneficial in treating both acute myocardial infarction (AMI) and ischemic heart failure (IHF). …

… The Cochrane Collaboration’s tool for assessing risk of bias in RCTs was used (Appendix
4… In addition, in all the five aspects of patient’s functional status (physical, role, emotional, …

Perceptions among women with breast cancer about the relative importance of different
potential chemotherapy side effects is not well understood. A survey was performed by women …

Objective. Our objective was to evaluate preferences associated with grade I/II and grade III/IV
chemotherapy side effects among breast cancer patients receiving chemotherapy. We …

Background Optimal dosing of bone-targeted agents (BTAs), in patients with bone
metastases remains an important clinical question. This trial compared 4-weekly versus 12-weekly …

… (n = 91, 58.3%) were cited in Beall’s list. The number of journals issued by each of these
publishers was found from the publisher’s website. This ranged from 6 for Imed Pub to 700 for …

… This study adds the patient’s perspective to validate the need of measuring an end point
in antiemetic trials that incorporates complete or total control of nausea and vomiting as a …

… The intervention(s) of interest were the use of peripheral access or central catheters,
including PICCs or PORTs for the administration of systemic chemotherapy. Only studies that …

Objectives The aim of the study was to identify the range of issues labeled as “non-financial
conflicts of interest” in biomedicine, articulate the associated concerns, and analyze the …